067080.KS · 대화제약

South Korea · RS rating 40 · As of 2026-10-14

Price10,350.00 KRW
1-day change-3.5%
RS rating (overall / 1M / 3M / 12M)40 / 37 / 79 / 24
StageDeclining
Composite / Minervini / CANSLIM score32 / 20 / 71
Industry group (rank)Medical-Generic Drugs (76)
EPS growth Q/Q+857.1%
Sales growth Q/Q+11.5%
Distance from 52-week high+55.6%
Market cap (USD)$164.7M
Open South Korea in the interactive screener